HOME >> MEDICINE >> NEWS
Helicobacter-pylori status might predict prognosis after surgery for gastric cancer

Patients who test negative for the bacterium Helicobacter pylori might have a worse prognosis after curative surgery for gastric cancer than those who are positive, according to researchers reporting in the March issue of The Lancet Oncology. "Tumour-specific immune responses might be downregulated in patients who are negative for H pylori and these patients should be followed up carefully because of a poor outlook", says lead author Dr Georgios Meimarakis (University of Munich, Germany).

Although H pylori has been associated with the development of gastric cancer, some patients are negative for H pylori. Gastric cancer is a disease with a poor outlook and therefore predictive factors are needed to identify early those who are at risk of relapse or death. Only a few studies have looked at whether H-pylori status is predictive of patient outlook. However, these studies were unable to answer this question definitively. Therefore, Meimarakis and colleagues assessed 166 patients who had had curative surgery for gastric adenocarcinoma between 1992 and 2002 and measured their survival in relation to their H pylori status.

After a median follow-up of 53 months, patients positive for H pylori had a relapse-free survival of 56.7 months and overall survival of 61.9 months compared with a relapse-free survival of 19.2 months and overall survival of 19.2 months for those who were H-pylori negative. Depth of tumour invasion, lymph-node metastasis, and older patient age were also prognostic factors for survival.

Dr Meimarakis states: "The identification of H-pylori status as an independent prognostic factor could be a useful tool in clinical practice to distinguish effectively between patients at high risk and low risk for adverse disease outcome. H-pylori status can be assessed easily in the clinic before resection. Thus, our study might contribute to a new classification of gastric cancer and have a substantial effect on disease outcome". If confimed, th
'"/>

Contact: Joe Santangelo
j.santangelo@elsevier.com
1-212-633-3810
Lancet
27-Feb-2006


Page: 1 2

Related medicine news :

1. Gene expression test reveals ER and HER-2 status of breast tumors
2. Only poor pay and low status of pediatrics helped women doctors buck discrimination
3. Rush University Medical Center maintains Magnet status for quality nursing
4. Northwestern Memorial earns magnet status for nursing excellence
5. Few gay man regret disclosing HIV status to friends, family
6. Study shows racial/ethnic disparities in medical/oral health status and care for minority children
7. Benefit of chemotherapy in breast cancer depends on estrogen-receptor status
8. Media telebriefing on new census, NIH status report citing dramatic shifts in US aging
9. Poor physical fitness associated with lower socioeconomic status and higher rate of death
10. Iron-rich rice improves iron status of women
11. Poor health, poverty and minority status are major factors in depression

Post Your Comments:
(Date:5/22/2013)... City, NJ (PRWEB) May 22, 2013 ... compliance, and management solutions for social enterprise collaboration ... LLC, a consulting firm based in Chicago, Ill. ... integrate their products and provide best-in-class solutions for ... and improve collaboration. , AvePoint’s DocAve Software ...
(Date:5/22/2013)... 22, 2013 BroadConnect Telecom, the ... IT security solutions in North America announced plans ... its newest BroadConnect hosted security solutions. Available on ... combination, BroadConnect’s new Security as a Service (SaaS) ... Internet connection of their choice, while optimizing internal ...
(Date:5/22/2013)... May 22, 2013 Asthma, a disorder ... and swell causes wheezing, shortness of breath, chest tightness ... occurs, the muscles surrounding the airways become tight and ... amount of air that can pass. Asthma attacks can ... airflow is severely restricted. Reuters reports that ...
(Date:5/22/2013)... May 22, 2013 Many people across ... for education on how to lose weight safely and ... challenging and may demotivate people to continue their journey ... discussed this week on Medical News Today ... to lose weight and actually losing those initial pounds ...
(Date:5/22/2013)... Poor adherence to appropriate medication therapy has been ... death (some 125,000 deaths in the U.S. every year ... It’s been estimated that between 33% and 69% of ... adherence — a reality that costs the American health-care ... is the degree of medication non-adherence — and the ...
Breaking Medicine News(10 mins):Health News:AvePoint Teams with Tahoe Partners, LLC to Enrich Microsoft SharePoint Deployments and Improve Collaboration 2Health News:AvePoint Teams with Tahoe Partners, LLC to Enrich Microsoft SharePoint Deployments and Improve Collaboration 3Health News:BroadConnect Telecom to Launch Enterprise-Grade Hosted Security Solutions Engineered to Meet the Demands of Real World Business 2Health News:hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Announce New hCG Diet Plans That May Reduce the Severity of Asthma Attacks 2Health News:hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Announce New hCG Diet Plans That May Reduce the Severity of Asthma Attacks 3Health News:hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Break the Cycle of Obesity and Weight Gain With New Education For Patients on How to Lose Weight the Healthy Way 2Health News:hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Break the Cycle of Obesity and Weight Gain With New Education For Patients on How to Lose Weight the Healthy Way 3Health News:Patient Prompt® Announces New Drug Adherence Program to Assist in Prescribed Medication Compliance 2
(Date:5/22/2013)... -- MarketReportsOnline.com announces addition of new market research ... Edition Material and Clinical Trial Requirements of Application ... of Registration Application for Imported Traditional Chinese Medicines ... The traditional medicines in Orient, especially, ... occidental as mysterious medicines. Until today not only ...
(Date:5/22/2013)... SAN FRANCISCO, Calif. , May 22, 2013 /PRNewswire/ ... today announced the clinical advancement of three programs in ... formulation of a JAK/SYK inhibitor, R348, being developed by ... other two programs are aimed at oncology targets and ... kinase inhibitor under development by BerGenBio AS (BerGenBio) and ...
(Date:5/22/2013)... , May 22, 2013 PRNewswire ... the production of a vaccine candidate for the ... third party laboratory using the iBioLaunch™ platform. This ... measured from initial antigen sequence information to purification ... http://photos.prnewswire.com/prnh/20120419/NY91086LOGO ) The iBioLaunch platform ...
Breaking Medicine Technology:China Pharmaceutical Market Guidebook Series (4) 2013 Report 2China Pharmaceutical Market Guidebook Series (4) 2013 Report 3China Pharmaceutical Market Guidebook Series (4) 2013 Report 4China Pharmaceutical Market Guidebook Series (4) 2013 Report 5Rigel's R348 to Initiate Phase 2 Clinical Trial in Dry Eye 2Rigel's R348 to Initiate Phase 2 Clinical Trial in Dry Eye 3Rigel's R348 to Initiate Phase 2 Clinical Trial in Dry Eye 4iBio Technology Produces Vaccine Candidate for Recently Emerged H7N9 Influenza 2
Cached News: